Real-World Effectiveness, Its Predictors and Onset of Action of Cholinesterase Inhibitors and Memantine in Dementia: A Retrospective Health Record Study of 7400 Individuals using the UK CRIS Platform
Lists
Only you see this
Abstract
Background<br/><br/>The efficacy of acetylcholinesterase inhibitors and memantine in the symptomatic treatment of Alzheimer’s Disease is well-established. Randomised trials have shown them to associate with a reduction in the rate of cognitive decline. The aim of this study was to investigate the real-world effectiveness of acetylcholinesterase inhibitors and memantine for dementia causing diseases in the largest UK observational secondary care service dataset to date.<br/><br/>Methods<br/><br/>We extracted mentions of relevant medications and cognitive testing (Mini-Mental State Examination - MMSE and Montreal Cognitive Assessment - MOCA scores) from de-identified patient records from two NHS Trusts. The 10-year changes of cognitive performance were modelled using a combination of generalized additive and linear mixed-effect modelling.<br/><br/>Results<br/><br/>We found that the initial decline in MMSE and MOCA scores occurs approximately 2 years before medication is initiated. Medication prescription stabilises cognitive performance for the ensuing 2 to 5 months. The effect is boosted in more cognitively impaired cases at the point of medication prescription and attenuated in those taking antipsychotics. Importantly, we identify that patients who switch at least once between agents do not experience any beneficial cognitive effect from pharmacological treatment.<br/><br/>Conclusion<br/><br/>This study presents the largest real-world examination of the efficacy of acetylcholinesterase inhibitors and memantine for symptomatic treatment of dementia. We found evidence that 68% of individuals respond to treatment with a period of cognitive stabilisation before continuing their decline at the pre-treatment rate.
BibTeX
@inproceedings{vaci2020real,
author = {Namanja Vaci and Ivan Koychev and Chi‐Hun Kim and Andrey Kormilitzin and Qiang Liu and Christopher Lucas and Azad Dehghan and Goran Nenadić and Alejo Nevado‐Holgado},
title = {{Real-World Effectiveness, Its Predictors and Onset of Action of Cholinesterase Inhibitors and Memantine in Dementia: A Retrospective Health Record Study of 7400 Individuals using the UK CRIS Platform}},
booktitle = {Research},
year = {2020},
}Loading related content...